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ABSTRACT
Background
Preterm labor, failure to progress, and postpartum hemorrhage are the common causes of
maternal and neonatal mortality or morbidity. All result from defects in the complex
mechanisms controlling labor, which coordinate changes in the uterine fundus, lower segment,
and cervix. We aimed to assess labor-associated gene expression profiles in these functionally
distinct areas of the human uterus by using microarrays.
Methods and Findings
Samples of uterine fundus, lower segment, and cervix were obtained from patients at term
(mean 6 SD¼39.1 6 0.5 wk) prior to the onset of labor (n¼6), or in active phase of labor with
spontaneous onset (n ¼ 7). Expression of 12,626 genes was evaluated using microarrays
(Human Genome U95A; Affymetrix) and compared between labor and non-labor samples.
Genes with the largest labor-associated change and the lowest variability in expression are
likely to be fundamental for parturition, so gene expression was ranked accordingly. From 500
genes with the highest rank we identified genes with similar expression profiles using two
independent clustering techniques. Sets of genes with a probability of chance grouping by
both techniques less than 0.01 represented 71.2%, 81.8%, and 79.8% of the 500 genes in the
fundus, lower segment, and cervix, respectively. We identified 14, 14, and 12 those sets of
genes in the fundus, lower segment, and cervix, respectively. This enabled networks of co-
regulated and co-expressed genes to be discovered. Many genes within the same cluster
shared similar functions or had functions pertinent to the process of labor.
Conclusions
Our results provide support for many of the established processes of parturition and also
describe novel-to-labor genes not previously associated with this process. The elucidation of
these mechanisms likely to be fundamental for controlling labor is an important prerequisite to
the development of effective treatments for major obstetric problems—including prematurity,
with its long-term consequences to the health of mother and offspring.
The Editors’ Summary of this article follows the references.
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PLoS MEDICINEIntroduction
The onset and progression of normal labor involves
complex maternal and fetal interactions leading to dilation
of the cervix and coordinated uterine contractions.
Temporal disruption of this process can lead to preterm
delivery, and ineffective uterine contractility can cause
failure to progress in labor or postpartum hemorrhage.
These problems have important consequences. Preterm
delivery is a major cause of neonatal mortality and morbidity,
including long-term neurological impairment [1]. Failure to
progress in labor may lead to maternal morbidity and/or
caesarean section [2] with its inherent risks, and postpartum
hemorrhage is one of the main causes of maternal mortality
worldwide [3].
Pregnancy is maintained by myometrial quiescence and
cervical resistance. Toward term, there is a progressive
activation of the myometrium and the cervix ripens in
preparation for labor. Labor is associated with dramatic
changes in myometrial contractions and cervical dilation
resulting from increased stimulatory and reduced inhibitory
processes [4]. These effects are due to simultaneous and
interdependent changes in cellular proteins initiated by a
multitude of genes. The molecular processes are spatially
coordinated to result in uterine contractions with simulta-
neous cervical dilation. Additional spatial organization of
contractile processes within the myometrium results in
increased contractility of the fundus compared to the lower
segment [4–7].
The speciﬁc changes in gene expression that cause these
temporal and spatial effects are largely unknown. Our
hypothesis is that labor results from the simultaneous change
in expression of a large number of genes that are organized
intoco-regulated networks. We examined the labor-associated
gene expression changes in the human fundus, lower segment,
and cervix using Affymetrix genome DNA microarrays.
Methods
Sample Collection
Tissue was obtained from patients undergoing cesarean
section and sterilization without medical or obstetrical
complications of pregnancy and who were not exposed to
medications immediately before enrollment. The procedure
was approved by the Institutional Review Board and Coventry
Research Ethics Committee (IRB 00-022, CREC 062/05/01),
and informed consent was obtained from all eligible patients.
Samples were obtained from patients at term (mean 6 SD ¼
39.1 6 0.5 wk) prior to the onset of labor (n ¼ 6), or in active
phase of labor with spontaneous onset (n ¼ 7). Labor was
Figure 1. Profiles of Gene Expression in the Uterine Fundus from Women before or after the Onset of Labor
Each panel shows profiles of the genes within one of the clusters determined jointly by K-means and hierarchical clustering. On the x-axis, samples from
individual patients are arranged and represented by vertical lines. Non-labor samples (gray background) are shown on the left and labor (white
background) on the right. The y-axis represents the level of gene expression as a number of standard deviations from the mean of all observations for
each gene (z-score).
DOI: 10.1371/journal.pmed.0030169.g001
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Gene Expression Profiles in Labordeﬁned as cervical dilatation of .3 cm or progressive dilation
accompanied by regular uterine contractions. Patients not in
labor were delivered by cesarean section on maternal request
following counseling by obstetrician because of previous
cesarean section or because an abnormal fetal presentation in
the index pregnancy made vaginal delivery unsafe. Patients in
labor had failure to progress despite adequate contractility or
fetal intolerance of labor.
For each patient, samples (approximately 1 cm
3) were
taken from the uterine fundus (the outside surface of the
uterus that does not include decidua), the lower segment at
the upper edge of the incision, and the anterior lip of the
cervix, through the vagina. We have previously shown that
our lower-segment samples are more than 98% myometrial
smooth muscle [8]. In one patient, a biopsy of the cervix could
not be obtained. Samples were immediately snap-frozen in
liquid nitrogen and stored at  80 8C.
Microarray Analysis
All samples were analyzed separately without pooling of
extracted RNA. RNA isolation was performed using TRIzol
Reagent (Gibco BRL Life Technologies, San Diego, California,
United States) followed by phenol extraction and ethanol
precipitation. Genomic contamination was removed by on-
column treatment of RNA samples with DNAse (27 Kunitz
units) for 20 min at 20 8C (Qiagen, Valencia, California,
United States).
Isolated total RNA was quantiﬁed by spectrophotometry.
Double-stranded cDNA was synthesized from total RNA using
T7-(dT)24 oligomer primer (Genset Corp., La Jolla, California,
United States) and Superscript II Reverse Transcriptase
(Gibco BRL Life Technologies). For complete recovery of
the cDNA, samples were subjected to phase-lock gel phenol-
chloroform extraction and ethanol precipitation. 1 lgo f
cDNA was used for an in vitro transcription reaction, which
involved the synthesis of the biotin-labeled cRNA from the
cDNA with biotinylated CTP and UTP (Enzo Life Sciences,
Farmingdale, New York, United States). The biotin-labeled
RNA fragments were then hybridized to microarray chips
(Human Genome U95A; Affymetrix, Santa Clara, California,
United States). Microarrays from several different lots were
used to analyze samples. Different lots of microarrays will
Figure 2. Profiles of Gene Expression in the Uterine Lower Segment from Women before or after the Onset of Labor
Each panel shows profiles of the genes within one of the clusters determined jointly by K-means and hierarchical clustering. On the x-axis, samples from
individual patients are arranged and represented by vertical lines. Non-labor samples (gray background) are shown on the left and labor (white
background) on the right. The y-axis represents the level of gene expression as a number of standard deviations from the mean of all observations for
each gene (z-score).
DOI: 10.1371/journal.pmed.0030169.g002
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Gene Expression Profiles in Laborincrease variability of ﬁndings but will minimize the chance
of a bias or systematic error associated with a certain lot and
resulting in false positive and negative ﬁndings. The chips
were washed, stained on a ﬂuidic station, and scanned by
confocal microscope. Each chip was used only once. The
average difference intensity was calculated and describes the
difference between the intensities of emitted light from
hybridized matched probes and their mismatched controls.
The average for the 20 probes and their controls are
calculated for each gene.
To allow comparison between genes and patients, average
difference intensities were converted into percentiles and z-
scores. To allow comparison between genes, the differences in
RNA hybridizations between probes and controls were
normalized by conversion into percentiles. To allow compar-
ison of samples (chip to chip), the percentile values were
converted into z-scores for a given gene expression across all
samples (expression value – mean/standard deviation).
Identiﬁcation of the putative gene functions used NetAffx
(Affymetrix), an integrated online resource from the Gen-
Bank, UniGene, and Gene Ontology databases, and the
Ingenuity database (http://www.ingenuity.com).
Statistical Methods
All samples were analyzed separately. To identify genes
demonstrating a maximal labor-associated change in expres-
sion, the p-value was calculated by Student’s t-test. This p-
value was used as a measure of the magnitude of the change
and inter-subject variability rather than to determine
signiﬁcance. Genes were ordered according to the p-value.
The 500 genes in each of the fundus, lower segment, and
cervix with the lowest p-values were selected for further
analysis.
These genes were clustered using two different techniques:
K-means and hierarchical. K-means is a non-hierarchical
clustering method that groups data points into a predeter-
mined number of clusters. It is an iterative process in which
each gene proﬁle is assigned to the closest centroid, which is
the center point of a cluster. The centroid is then
recomputed until a steady state has been reached. Euclidian
distance was used as a similarity measure for gene proﬁles.
Centroids were initialized using a data-based centroid search.
The number of clusters was selected to provide a wide range
of genes per cluster without uninformative clusters contain-
ing no or single genes.
Hierarchical clustering arranges the genes on a treelike
system. Clusters are merged if the expression proﬁles are
similar. The similarity between gene expression proﬁles was
calculated using Euclidian distance and between clusters
using unweighted pair-group method with arithmetic mean.
Genes clustered together by both techniques were identiﬁed.
Coincidence testing [9] was used to determine whether co-
clustering was likely to have arisen by chance. Figures 1–3
depict clusters of genes grouped together by both methods
where probability of chance co-clustering was p , 0.01.
Within each of the coincidence clusters, we identiﬁed genes
with functions similar to other genes within the same cluster
or functions pertinent to the process of labor. For this
purpose we used an interactive database of gene functions
and interactions (Ingenuity pathway analysis) and biological
knowledge database (http://www.ingenuity.com).
Figure 3. Profiles of Gene Expression in the Uterine Cervix from Women before or after the Onset of Labor
Each panel shows profiles of the genes within one of the clusters determined jointly by K-means and hierarchical clustering. On the x-axis, samples from
individual patients are arranged and represented by vertical lines. Non-labor samples (gray background) are shown on the left and labor (white
background) on the right. The y-axis represents the level of gene expression as a number of standard deviations from the mean of all observations for
each gene (z-score).
DOI: 10.1371/journal.pmed.0030169.g003
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Gene Expression Profiles in LaborTable 1. Fundus: Selected Genes within Each of the Coincidence Clusters with Functions Similar to Other Genes within the Same
Cluster or Functions Pertinent to the Process of Labor
Cluster GenBank
ID
Gene
Name
Change Fold p Function
1 U72511 Repressor of estrogen receptor
activity
  1.72 0.0120 Inhibits activity of liganded estrogen
receptors a and b
1 X52773 Retinoid X receptor alpha   1.22 0.0412 Binds estrogen receptor a (ERA) and
estrogen response element (ERE)
1 X89416 Protein phosphatase 5 catalytic
subunit
  1.46 0.0197 Estrogen inducible, binds ERA and ERE,
binds protein phosphatase 2A
1 M65254 Protein phosphatase 2 regulatory
subunit A
beta isoform
  1.10 0.0039 Activates MARCKS-actin cross-linking
proteins
1 D10495 Protein kinase C, delta   1.61 0.0015 Inhibits P/Q Ca channels and releases
nitric oxide
1 M60165 G protein alpha polypeptide O   0.90 0.0399 Inhibits voltage-gated and L-type Ca
channels, and adenylate cyclase
1 U95626 Chemokine receptor 5   1.54 0.0116 Progesterone stimulated chemokine
receptor binding cytokines (e.g., IL-8)
1 AF024578 Protein phosphatase 1, inhibitory
subunit 3A
  1.02 0.0424 Increases concentration of glycogen in
muscle cells; is Ca inhibited
2 X16302 Insulin-like growth factor binding
protein 2
þ 1.89 0.0162 Inhibited by EGF; stimulated by estrogens
2 AF040723 Huntington-associated protein 1—
neuroan 1
þ 1.58 0.0233 Decreases degradation of EGF receptor;
involved in synaptic transmission
2 AF009624 Kinesin 17 þ 3.15 0.0308 Increases expression of a channel
involved in potentiation of synaptic
transmission
2 D63485 Inhibitor of NFkB-inducing kinase
epsilon
þ 1.83 0.0201 NFKB-inducing kinase
3 X89066 Transient potential cation channel C 1 þ 2.50 0.0333 Increases influx of calcium into cell,
store-operated calcium channel
3 L31584 Chemokine receptor 7 þ 2.67 0.0288 Increases intracellular calcium and actin
polymerization; is PGE2 induced
3 AF055033 Insulin-like growth factor (IGF) binding
protein 5
þ 1.25 0.0355 PGE2 and estradiol induced; stimulates
IGF1 in smooth muscle cells
3 U50748 Leptin receptor þ 2.55 0.0430 Increases lipolysis and glucose uptake in
the muscle cells
4 U26742 Dystrobrevin alpha þ 1.91 0.0003 Neuromuscular junction function
4 AF011406 Corticotropin releasing hormone
receptor 2
þ 1.45 0.0022 Increases phosphorylation of myosin light
chain
4 X66141 Regulatory light chain of myosin þ 2.41 0.0242 Ca-stimulated phosphorylation triggers
muscle contraction
4 M60459 Erythropoietin receptor þ 1.80 0.0027 Ca channel activator; present in the
muscle cells
4 L25119 Opioid receptor mu 1 þ 2.55 0.0291 Increases intracellular Ca, stimulates
PLA2, and inhibits adenylate cyclase
4 M17017 Interleukin 8 þ 1.31 0.0144 Increases intracellular calcium, activated
by NFKB
4 M16441 Tumor necrosis factor b þ 1.16 0.0227 Activates NFKB
4 J02625 Cytochrome P450 IIE 1 þ 2.55 0.0054 Increases concentration of PGE2
5 X68149 Burkitt lymphoma receptor 1, G
protein–coupled
chemokine receptor 5
  3.23 0.0279 Chemokine receptor regulated by NFKB
5 U53003 Chromosome 21 open reading frame 33   1.43 0.0111 Expression regulated by NFKBIA and TNF
5 X62055 Protein tyrosine phosphatase, non-receptor
type 6
  2.99 0.0119 Inhibits Ca mobilization, regulated by TNF
5 Y08110 Sortilin-related receptor 1   2.05 0.0264 Lipid and protein transport, regulated by
TNF receptor-TNFRSF6
6 D78586 Carbamoyl-phosphate synthetase 2,
aspartate
transcarbamylase, and dihydroorotase
þ 2.00 0.0158 Pyrimidine synthesis; expression increased
by estrogen
6 U96876 Insulin induced gene 1 þ 2.06 0.0054 Transcription regulator; present in muscle
cells
6 M60618 Nuclear transcription regulator Sp100 þ 2.25 0.0252 Transcription repressor
6 X89750 TGFB-induced factor þ 2.05 0.0316 Transcription co-repressor
6 X76091 Regulatory factor X 2 þ 1.92 0.0069 Transcription regulator
7 M24486 2-oxoglutarate 4-dioxygenase alpha þ 1.15 0.0178 Expression increased by hypoxia and
inhibited by PGI2
7 D11466 Phosphatidylinositol glycan A þ 2.51 0.0276 Transferase of glycosyl groups; role in
cell damage
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Gene Expression Profiles in LaborValidation of the Microarray Findings
Labor-associated changes in the expression of selected
genes were examined using RT-PCR. Reaction products were
separated, detected, and quantiﬁed with chip-based gel
electrophoresis (Agilent 2100 bioanalyzer; Agilent Technolo-
gies, Palo Alto, California, United States) as described
previously [10]. The number of PCR cycles (35) was selected
from the linear portions of the dynamic ranges of ampliﬁ-
cation. The quantiﬁcation and sizing coefﬁcients of variation
are ,6.7% and ,2.1%, respectively [11]. All mRNA abun-
dance data were expressed relative to constitutively expressed
18S rRNA. The non-labor and labor samples were compared
using the Mann-Whitney U test.
Results
We analyzed the expression of 12,626 known genes in
biopsies taken from the fundus, lower segment, and cervix
either before (n ¼ 6) or after the onset of labor (n ¼ 7). The
expression of each gene was quantiﬁed using an Affymetrix
gene microarray. Student’s t-test was used to determine the p-
value for the difference in gene expression in samples taken
before or after labor. This test identiﬁes those genes with the
Table 1. Continued
Cluster GenBank
ID
Gene
Name
Change Fold p Function
8 M68941 Protein tyrosine phosphatase, non-receptor
type 4
þ 1.87 0.0136 Signal transduction downstream of the
glutamate receptor
8 X90530 GTP-binding protein ragB þ 2.13 0.0302 Signal transduction
8 X86019 Wiskott-Aldrich syndrome protein interacting
protein
þ 1.27 0.0365 Signal transduction from cell surface
receptors to actin cytoskeleton
8 AL030996 THO complex 2 þ 1.67 0.0078 Transcription complex element
9 L22475 BCL2-associated X protein   1.87 0.0024 Decreases intracellular Ca storage
9 M80563 S100 calcium-binding protein A4   1.85 0.0440 Ca-binding protein decreasing ATPase
activity of myosin
9 Y12336 RAS guanyl releasing protein 2—
guanine nucleotide exchange factor
  2.13 0.0364 Stimulates RhoA Ca sensitization–dependent
maintenance of contraction
9 M13981 Inhibin alpha   2.21 0.0345 Stimulated by antiprogestins, synergistic with
progesterone, and inhibited by indomethacin
10 M27318 Interferon alpha 4   1.75 0.0188 Increases expression of IFNG (gamma)
10 U11870 Interleukin 8 receptor alpha   2.26 0.0393 Upregulated by INFG
10 D14838 Fibroblast growth factor 9   1.75 0.0220 Activated by INFG
10 W27605 Cone-rod homeobox gene   3.02 0.0226 Increases PDE6-cGMP-specific phosphodiesterase
10 X67594 Melanocortin 1 receptor   1.72 0.0195 Activates adenylate cyclase; binds POMC
10 AA846749 Apolipoprotein M   1.76 0.0003 Lipid transporter in energy pathway; inhibited
by POMC
11 U80017 Baculoviral IAP repeat-containing 1   1.72 0.0006 Apoptosis inhibitor
11 D29013 Polymerase beta   1.38 0.0367 Apoptosis inhibitor
11 M15024 v-myb myeloblastosis viral oncogene   1.20 0.0432 Apoptosis inhibitor
11 U76388 Steroid hormone nuclear receptor 5 A1   1.96 0.0054 Increases cAMP-mediated progesterone synthesis
11 U15422 Protamine 2   0.75 0.0290 Dephosphorylates glycogen synthase
12 U96781 Caþþ transporting ATPase in sarcoplasmic
reticulum
  1.82 0.0021 Ca-ransporting ATPase in sarcoplasmic reticulum;
K activated
12 X63575 Caþþ transporting ATPase in plasma membrane   1.58 0.0256 Ca-transporting ATPase in plasma membrane;
K activated
12 D49919 Chemokine receptor 8   1.04 0.0311 Increases intracellular Ca; inhibited by E2
12 X83228 Cadherin 17   2.07 0.0100 Ca-dependent protein transporter and cell-adhesion
molecule
12 D78011 Dihydropyrimidinase   1.69 0.0096 Inhibits L-type voltage-gated Ca channel
12 AL034562 Prodynorphin   1.48 0.0268 Ca stimulated, induces release of CGRP, which
increases
cAMP and Ca
12 AF035594 Protein kinase C-alpha   0.99 0.0357 Ca-dependent regulation of Na/K ATPase in
sarcolemma
12 J05428 UDP glycosyltransferase 2   1.24 0.0166 Increases glucuronidation of E but not of P
12 D32202 Adrenergic alpha-1A receptor   1.84 0.0254 Increases smooth muscle tone via RhoGEF
activation
12 AB008430 FERM, RhoGEF-Rho guanine nucleotide exchange
factor
  1.08 0.0432 Stimulates RhoA Ca sensitization–dependent
maintenance of contraction
12 L26584 Ras protein-specific guanine nucleotide-
releasing/exchange factor 1
  1.07 0.0238 Stimulates RhoA Ca sensitization–dependent
maintenance of contraction
12 W27674 Guanylate cyclase activator 1A   1.15 0.0262 Ca-sensitive guanylate cyclase activator
Cluster number identifies a coincidence cluster of genes grouped together by K-means and hierarchical clustering methods where probability of chance co-clustering was p , 0.01. The
fold change is a ratio of the difference between labor and non-labor medians of gene expression to the non-labor median level of gene expression. The change sign indicates the direction
of the expression change in the labor samples compared to non-labor. The p-value is given for the difference in gene expression in samples taken before and after labor. Gene function is
derived from the database of gene functions and interactions Ingenuity Pathway Analysis and Biological Knowledge Database.
DOI: 10.1371/journal.pmed.0030169.t001
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Gene Expression Profiles in LaborTable 2. Lower Segment: Selected Genes within Each of the Coincidence Clusters with Functions Similar to Other Genes within the
Same Cluster or Functions Pertinent to the Process of Labor
Cluster GenBank ID Gene Name Change Fold p Function
1 AB015228 Aldehyde dehydrogenase 1 A2   1.62 0.0048 Apoptosis
1 M15059 Fc fragment of IgE   1.44 0.0231 Apoptosis
1 AL080218 Transcription activator STAT 5   2.63 0.0274 Apoptosis
1 U09759 Mitogen-activated protein kinase 9   1.73 0.0143 Apoptosis and cell growth
1 X75621 Tuberin GTPase activator   1.89 0.0112 Cell growth
1 M30448 Casein kinase-fibrillarin   1.70 0.0257 Cell growth
1 U50939 Amyloid beta precursor protein–binding protein   2.08 0.0267 Apoptosis
1 AJ132917 Methyl CpG–binding protein 2   1.63 0.0353 Cell size
1 M28211 Rho GTPase   1.67 0.0016 Cell size
2 D88827 Zinc finger protein 263 þ 1.56 0.0351 Regulation of transcription
2 AF053944 AE binding protein 1 þ 2.01 0.0027 Transcription factor in muscle development
3 AL022329 Beta-adrenergic receptor kinase 2 þ 2.53 0.0254 Inhibits voltage-gated Ca channels and increases cAMP
3 U56998 Cytokine-inducible kinase þ 1.87 0.0080 cAMP-dependent and ATP-binding kinase involved in apoptosis
3 X63575 ATPase, Caþþ transporting, plasma
membrane 2
þ 2.48 0.0055 Calmodulin-binding Ca-transporting ATPase
3 X60201 Brain-derived neurotrophic factor þ 2.21 0.0133 Cell proliferation
3 M60828 Fibroblast growth factor 7 (keratinocyte
growth factor)
þ 1.98 0.0076 Cell proliferation
3 U96876 Insulin-induced gene 1 þ 1.53 0.0073 Cell proliferation
4 Z22555 Scavenger receptor class B 1 þ 2.17 0.0273 Increases uptake of LDL and triacyl glycerol
4 L13939 Adaptor-related protein complex 1, beta 1 subunit þ 1.14 0.0349 Involved in endocytosis and vesicle transport
5 U77914 Jagged 1 gene   1.66 0.0115 Cell differentiation, growth and apoptosis
5 L76517 Presenilin 1   1.69 0.0139 Cell differentiation, growth and apoptosis
5 X56687 RNA polymerase I transcription factor   2.41 0.0140 Cell growth and death
5 X05608 Neurofilament light polypeptide   1.54 0.0084 Cell growth and death
5 U11791 Cyclin H   1.80 0.0297 Temporal coordination of mitosis
6 L76380 Calcitonin-like receptor þ 1.71 0.0211 Increased production of cAMP and mobilization of Ca
binds CGRP
6 M22430 Phospholipase A2, IIA þ 1.83 0.0056 Increases expression of INOS and PGE2
6 AA004795 Amyloid beta precursor protein 2–binding
protein
þ 2.03 0.0291 Ca-binding protein in the heart
6 J00068 Actin alpha 1 þ 1.37 0.0198 Muscle contractility
6 L76571 Nuclear receptor 0 B 2 þ 1.18 0.0087 Orphan receptor inhibiting activity of estrogen and thyroid
hormone receptors
6 X13967 Leukemia inhibitory factor þ 1.27 0.0193 Cell proliferation and growth
6 X62055 Protein tyrosine phosphatase, non-receptor
type 6
þ 1.48 0.0174 Cell proliferation and growth
6 X82240 T-cell leukemia þ 1.62 0.0026 Cell proliferation and growth
7 X66363 PCTAIRE protein tyrosine kinase 1 þ 1.00 0.0227 Protein phosphorylation in sarcolemma
7 N36295 Dolichyl-mannosyltransferase regulatory
subunit 2
þ 2.51 0.0015 Protein glycosylation; regulates glycosylphosphatidylinositol
synthesis
7 M16750 Pim-1 protein tyrosine kinase þ 1.48 0.0325 Protein phosphorylation; involved in cardiac hypertrophy
8 L13463 Regulator of G protein signaling 2   2.78 0.0343 Decreases Ca release and response to cAMP
8 U19261 TNF receptor-associated factor 1   1.75 0.0166 Mediates TNF-a activation of NFkB and MAPK8/JAK and cell
apoptosis
8 AF041381 E2F transcription factor 6   2.24 0.0258 Suppressor of transcription; regulated by TNFRS5 a TRAF1
receptor
9 U95626 Chemokine receptor 5   1.99 0.0227 Regulated by IL-4 and TNF; involved in cell apoptosis
9 Y14737 Immunoglobulin heavy constant gamma 3   2.13 0.0206 Regulated by IL-4; regulates TNF; involved in cell apoptosis
9 X76079 Platelet-derived growth factor receptor, alpha
subunit
  1.97 0.0205 Cell apoptosis
9 AJ001366 Potassium voltage-gated channel H 1   2.49 0.0198 Activated by membrane depolarization and inhibited by
intracellular Ca
2þ
10 AF015950 Telomerase reverse transcriptase   1.37 0.0180 Cell apoptosis
10 U58334 Tumor protein p53 binding protein, 2   1.24 0.0068 Cell apoptosis
10 S69369 Paired box gene 3   1.94 0.0099 Cell apoptosis
10 X87176 17-beta hydroxysteroid dehydrogenase 4   1.75 0.0065 Progesterone-stimulated; facilitates conversion of E2 to E1
11 AJ001015 Calcitonin receptor activity–modifying protein 2   1.28 0.0296 Facilitates effect of adrenomedullin
11 U18760 Nuclear transcription factor I/X   1.30 0.0192 CCAAT-binding transcription factor regulated by ADRA1
11 D50929 Eukaryotic translation initiation factor 3   1.55 0.0173 Translation regulator
11 AF049703 E74-like factor 5   1.48 0.0090 Transcription regulator
12 M14083 Plasminogen activator inhibitor type 1, member 1 þ 1.49 0.0098 Cell migration and tissue formation
12 AI743134 Plasminogen activator inhibitor type 1, member 2 þ 1.42 0.0308 Cell migration and tissue formation
12 X57766 Matrix metalloproteinase 11 (stromelysin 3) þ 1.08 0.0208 Cell migration and tissue formation
12 M23379 RAS p21 GTPase activator 1 þ 1.06 0.0240 Cell migration and tissue formation
12 X12451 Cathepsin L þ 2.49 0.0313 Cell migration and tissue formation
13 U34584 BCL2-interacting killer (apoptosis-inducing)   1.81 0.0148 Cell apoptosis
13 U05340 CDC20 cell division cycle 20 gene   1.96 0.0056 Cell apoptosis
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Gene Expression Profiles in Laborlargest labor-associated change in expression and the lowest
variability. The 500 genes with the lowest p-values were
selected from fundus (Dataset S1), lower segment (Dataset S2),
and cervix (Dataset S3). Of the 500 genes with the largest
change in expression, 28 were common to both the fundus
and lower segment. This ﬁnding suggests that a small core of
genes is associated with labor in both the upper and lower
segments of the uterus. Most changes in gene expression
however, are not common, supporting the hypothesis of
differential spatial regulation [12]. In both areas of the uterus,
labor was associated with an overall reduction, rather than
increase in gene expression. Expression was reduced in
71.4%, 72.4%, and 79.2% of the 500 genes after the onset
of labor in the fundus, lower segment, and cervix, respec-
tively.
Since many genes in reproductive tissues may be co-
regulated or interdependent, we identiﬁed groups of genes
with similar expression proﬁles. We placed the selected 500
genes into one of ten clusters. Two different techniques were
used: K-means and hierarchical. The number of genes per
cluster determined by K-means ranged between 31–83, 26–93,
and 115–102 for fundus, lower segment, and cervix, respec-
tively. The corresponding number of genes for each cluster by
hierarchical clustering was 3–239, 3–181, and 2–333, respec-
tively. To further reﬁne the gene groups we determined those
genes which were co-clustered using both techniques.
Coincidence testing was done to determine the probability
that each set of genes was co-clustered using both techniques
by chance. Sets of genes with a probability of chance
grouping less than 0.01 were analyzed further. These sets
represented 71.2%, 81.8%, and 79.8% of the 500 genes in the
fundus, lower segment, and cervix, respectively. Since genes
grouped by one technique can also be grouped in any of the
ten groups from the second technique, there are 100 possible
co-clusters. We found only 14, 14, and 12 clusters in the
fundus, lower segment, and cervix, respectively, suggesting
that these co-clusters are likely to represent interdependent
or co-regulated genes. Examples of genes clustered together
by both techniques are shown in Tables 1–3. (Complete data
are available online and can be accessed at http://www.ebi.ac.
uk/arrayexpress, accession number E-MEXP-106).
Examination of the data raises some interesting hypoth-
eses. For example, in the lower segment, expression of the
genes for the nuclear binding protein C/EBP, TNF receptor,
alpha 1A–adrenergic receptor, phospholipase A2 (group IIA),
and G protein–coupled receptor 18 have similar expression
proﬁles. In the fundus, the expression of repressor of
estrogen receptor activity (REA) is reduced, while prothymo-
sin alpha remains unchanged with labor. The two genes
constitute one of the reported regulatory pathways of
estrogen receptor alpha (ERA) activity [13].
Numerous genes have been reported to change in
expression dramatically in reproductive tissues at the onset
of labor. Our results are consistent with these previous results
and demonstrate in the lower segment a marked increase in
expression of the genes for beta-adrenergic receptor kinase 2
[14], phospholipase A2 IIA [15], and calcium ion–transporting
ATPase 2 [16]. Furthermore, there was a reduction in
expression of regulator of G protein signaling 2 [17],
calcitonin receptor activity–modifying protein 2 [18], and
protein kinase C [19]. Nevertheless, some genes that would be
expected to demonstrate a marked labor-associated increase,
such as prostaglandin receptor EP 4 [20], were not selected by
our technique, possibly due to a large inter-patient variability
in expression. Since other genes’ expression patterns were
consistent with prior ﬁndings, this variability may reﬂect gene
polymorphism.
Expression changes of REA, retinoid X receptor alpha
(RXR), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) in association with labor in the uterine fundus
corresponded to the ﬁndings of microarray experiments.
Both REA and RXR expressions decreased in labor, while
expression of GAPDH remained unchanged (Figure 4).
Discussion
Our results demonstrate labor-associated changes in gene
expression in three functionally important areas of the
Table 2. Continued
Cluster GenBank ID Gene Name Change Fold p Function
13 U58334 Tumor protein p53–binding protein, 2   1.42 0.0306 Cell apoptosis
13 AF001383 Bridging integrator 1   1.56 0.0038 Cell apoptosis
13 AF018253 Tumor necrosis factor receptor 11a   1.72 0.0228 Cell apoptosis
13 U83600 Tumor necrosis factor receptor 25   1.12 0.0202 Cell apoptosis
13 AI193606 Potassium channel K 3   2.57 0.0050 Decreases depolarization and excitation
13 U39196 Potassium inwardly rectifying channel J 3   1.22 0.0322 Increase of Kþ efflux; shortening of action
potential; activated by ADRA1A
13 D25235 Adrenergic alpha-1A receptor   2.22 0.0256 Activates KCNJ3
13 AJ224874 Voltage-gated calcium channel alpha 1F subunit   1.38 0.0301 Tonically active over large range of voltage
14 U60521 Caspase 9, apoptosis-related cysteine protease   3.14 0.0350 Cell apoptosis
14 M89470 Paired box gene 2   2.01 0.0229 Cell apoptosis
14 M22976 Cytochrome b-5   2.30 0.0047 Cell apoptosis
14 Y10659 Interleukin 13 receptor, alpha 1   2.46 0.0010 Regulated by IL4 and IL13
14 L41067 Nuclear transcription factor calcineurin-dependent 3   1.73 0.0213 Regulates IL4 and IL13
Cluster number identifies a coincidence cluster of genes grouped together by K-means and hierarchical clustering methods where probability of chance co-clustering was p , 0.01. The
fold change is a ratio of the difference between labor and non-labor medians of gene expression to the non-labor median level of gene expression. The change sign indicates the direction
of the expression change in the labor samples comparing to non-labor. The p-value is given for the difference in gene expression in samples taken before and after labor. Gene function is
derived from the database of gene functions and interactions Ingenuity Pathway Analysis and Biological Knowledge Database.
DOI: 10.1371/journal.pmed.0030169.t002
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Gene Expression Profiles in LaborTable 3. Cervix: Selected Genes within Each of the Coincidence Clusters with Functions Similar to Other Genes within the Same Cluster
or Functions Pertinent to the Process of Labor
Cluster GenBank ID Gene Name Change Fold p Function
1 L32976 Mitogen-activated protein kinase 11   1.89 0.0386 Cell apoptosis
1 U07418 DNA mismatch repair gene   1.95 0.0057 Cell apoptosis
1 X87843 Transcription regulator factor gene MNAT1   1.89 0.0412 Cell apoptosis
1 AF015950 Telomerase reverse transcriptase   1.48 0.0335 Cell growth; cell cycle progression
1 AF034780 Sphingolipid G protein–coupled receptor 5   1.50 0.0347 Cell growth; cell cycle progression
1 U82130 Tumor susceptibility gene 101-transcription
regulator gene
  2.16 0.0491 Cell growth; cell cycle progression
1 AL049386 Transcription regulator gene Notch2   1.61 0.0069 Cell growth
1 M34423 Beta 1 galactosidase   1.45 0.0427 Lysosomal enzyme
1 X76488 Lipase A   1.91 0.0140 Lysosomal enzyme
1 AF046888 Tumor necrosis factor (TNF) 13   1.09 0.0413 Activates NFKB and cell apoptosis
1 U59863 TNF receptor–associated (TRAF) NFKB activator   1.70 0.0265 Increases IL-8 and TRAF2–mediated activation of NFKB
1 S74720 Orphan nuclear steroid hormone receptor B1   0.88 0.0465 Decreases activity of ERA and ERB
1 U51903 GTPase-activating protein 2   2.03 0.0070 Cross-linkage of actin filaments
2 AL022310 Tumor necrosis factor 4 þ 1.14 0.0220 Increases activation of NFKB
2 U48730 Signal transducer and activator of transcription 5B þ 1.41 0.0289 Transcription factor activated by TNF and other cytokines
2 M33684 Protein tyrosine phosphatase, non-receptor type 1 þ 1.41 0.0366 Signal transduction gene regulated by TNF
2 AA292277 Nuclear transcription co-activator 4 þ 1.41 0.0441 Inhibits expression of TNF and IL8; NFKB decreases its
nuclear import
2 AI961040 Tubulin, gamma complex–associated protein 2 þ 2.10 0.0113 Protein binding to IL8 receptors A and B
2 M36653 POU domain 2 transcription factor 2 þ 1.64 0.0372 Increases activity of CCR5 chemokine receptor for IL8
2 X07109 Protein kinase C beta 1 þ 1.35 0.0077 Increases activity of NFKB and is activated by IL8 and TNF
3 D43945 Transcription factor EC þ 1.93 0.0407 GTP-binding translation initiating factor
3 L19161 Translation initiation factor 2, subunit 3 þ 2.12 0.0309 Transcription regulating factor
3 U78575 Phosphatidylinositol-4-phosphate 5-kinase alpha I þ 1.96 0.0354 Increases activity of EGFR, which stimulates interstitial
collagenase MMP1
3 X90579 Cytochrome P450 IIIA, polypeptide 5 pseudogene 2 þ 2.16 0.0312 Metabolizes progesterone
4 L37042 Casein kinase 1, alpha 1   2.14 0.0375 Cell apoptosis
4 U59435 Proliferation-associated metallopeptidase 2G4   1.51 0.0420 Proteo and peptidolysis
5 M36803 Hemopexin   2.07 0.0273 Enhances TIMP inhibition of MMP degradation of
extracellular matrix
5 U33821 Tax1-binding protein 1   1.74 0.0324 Apoptosis inhibitor
5 M11186 Prepro-oxytocin (neurophysin I)   1.76 0.0018 Increases prostaglandin E2 synthesis
5 U07620 Mitogen-activated protein kinase 10   1.25 0.0053 Mediates cytokine-induced prostaglandin synthesis
6 M18079 Fatty acid–binding protein 2, intestinal   1.23 0.0254 Increases fat oxidation and insulin resistance; is inhibited
by collagen
6 D31766 Glucosamine-6-phosphate isomerase   1.72 0.0326 Energy pathway
6 X13916 Low-density lipoprotein-related protein 1   1.80 0.0121 Mediates catabolism of MMP-9
7 X65293 Protein kinase C, epsilon   1.35 0.0033 Activates NFKB and cell apoptosis
7 AF053977 Anaphase-promoting complex protein member gene   1.50 0.0384 Decreases cell proliferation
8 X72308 Chemokine ligand 7 þ 1.31 0.0240 Chemotaxis of monocytes and leukocytes
8 U03905 Chemokine receptor 2 þ 1.14 0.0217 Receptor for CCL7; chemotaxis of monocytes and
leukocytes
8 X80343 Cyclin-dependent protein kinase 5 activator—
regulatory subunit
þ 1.14 0.0489 Cell growth and differentiation
8 W28588 Neurofilament light polypeptide þ 1.57 0.0273 Cell growth and differentiation
8 L41827 Neuregulin 1 þ 1.16 0.0268 Cell growth and differentiation
8 X07024 TAF1 RNA polymerase II transcription co-activator þ 2.13 0.0426 Cell growth
8 M25269 ELK1 transcription regulator þ 1.62 0.0121 Cell growth
8 U94902 Transmembrane receptor–binding collagen and
hyaluronic acid
þ 2.03 0.0387 Cell growth and proliferation of connective tissue cells
8 M69136 Mast cell’s chymase 1 þ 2.00 0.0291 Peptidase degrading extracellular matrix
8 AC002366 Amelogenin þ 1.37 0.0036 Extracellular matrix glycoprotein
8 M31153 Cytochrome P450 XVII—steroid 17-alpha-hydroxylase þ 1.73 0.0486 Key enzyme in steroidogenesis of estrogens and androgens
9 U69108 TNF receptor–associated factor 5 þ 0.95 0.0372 Mediates TNF-induced NFKB activation and protection
from cell death
9 U40705 Telomeric repeat binding factor 1 þ 1.68 0.0198 Induces mitotic entry and apoptosis
10 X84709 Adaptor protein for TNF receptors—FAS associated   4.68 0.0419 Apoptosis of fibroblasts
10 X91648 Purine-rich element binding protein A   1.29 0.0108 Apoptosis of fibroblasts
10 M29870 Rho small GTP binding protein Rac1   2.18 0.0094 Apoptosis of fibroblasts; regulates various MAPK
10 U07620 Mitogen-activated protein kinase 10   2.26 0.0474 Cell death and apoptosis
10 U33052 Protein kinase C–like 2   1.98 0.0112 Cell death and apoptosis regulated by rho proteins
10 Z75311 Single-stranded specific endoDNAase RAD50   1.27 0.0116 Cell death and apoptosis
10 AL046322 Karyopherin alpha 6   1.56 0.0374 Cell apoptosis
10 Y12670 Leptin receptor   1.57 0.0498 Cell apoptosis
11 U52960 RNA polymerase II transcription regulator   1.09 0.0419 Transcription regulator binding CREBBP
11 J02621 High-mobility group nucleosome binding domain 1   1.35 0.0255 Transcription factor that is regulated by CREBBP
11 X96924 Mitochondrial carrier protein 25-1   1.29 0.0466 Expression is increased by HNF4A activated by CREBBP
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Gene Expression Profiles in Laborhuman uterus. The primary objective of this study was to
identify novel-to-labor genes important for the process of
parturition. The second main objective was to identify groups
of genes with similar expression proﬁles in order to recognize
those with common regulatory mechanisms. Rather than
providing a list of genes, this results provides a map of gene
interactions in labor. We postulated that the onset of labor is
likely to be caused by a reduction in inhibitory and an
increase in stimulatory processes, and our data support this
theory; for example, we demonstrated that in the lower
segment in labor expression of genes for the stimulatory
tumor necrosis factor receptor is increased, whereas that of
the relaxatory potassium channel is reduced.
The study was speciﬁcally designed to investigate gene
expression in human labor because the mechanisms of labor
vary between species. Previous gene array studies have
d o c u m e n t e dc h a n g e si ne x p r e s s i o ni nar o d e n tm o d e l
[21,22]. Such animal models are useful since variability is
reduced because of the animals’ similar genotypes and
exposure to a controlled environment. Expression data from
such studies can be compared and contrasted with those from
human tissue, thus providing an insight into the similarities
and differences between species. However, we consider that
data from human studies are the most important for
understanding human physiology.
Previous human gene array data [22,23], has marked
differences in methodology from our study. Bethin and
colleagues [22] determined the expression proﬁle in human
extracts obtained either preterm, prior to labor or preterm,
and at term following the onset of labor. In contrast, we
designed our study to speciﬁcally determine labor-associated
alterations and to exclude the marked changes in expression
at the end of pregnancy. A further difference in our study was
that we analyzed human uterine samples from all three
functionally distinct areas of the uterus in the same women. It
is the cooperation of these components of the uterus
(contraction of the fundus, relaxation of the lower segment,
and dilation of the cervix) that result in the process of labor.
Our study also differed in that the method of analysis and
sample size enabled the individual variation between women
to be taken into account—i.e., to preserve these character-
istics samples were not pooled. This individual analysis
enabled the expression of each gene to be identiﬁed in each
sample. The genes were then grouped into clusters based on
their similarity of expression across individual samples. This
similarity of genes’ expressions in different samples dramat-
ically increases the power of the cluster analysis and is
possible only because the individual sample characteristics
are maintained. However, one limitation of an individual
analysis is that individual variation in expression in human
tissue is likely to be high, not only because there are marked
genetic and environmental effects but also because the time
to the onset of spontaneous labor in non-labor samples is not
known.
Aguan and colleagues utilized a different experimental
design and methodology to investigate gene expression in the
lower uterine segment before and after the onset of labor
[23]. The type of array, number of investigated genes (588),
and normalization procedures make valid comparison with
our study difﬁcult. The studies differ also in how the fold
change in the gene expression calculation was done. How-
ever, there are several consistent changes in gene expression.
For example, we demonstrated a 91% decrease in G protein–
coupled receptor 161 in lower-segment samples, which is
consistent with the 84% reduction reported by Aguan et al.
We also demonstrated consistent changes in guanine nucleo-
tide binding protein alpha expression.
Chan and colleagues [24] studied uterine samples in labor
using a subtractive hybridization technique. Although this
study used a different technique from ours, and the number
of genes upregulated in labor was small, their ﬁndings have
shown a consistent with our results, signiﬁcant increase in the
expression of interleukin-8.
Gene array data provide a wealth of information, which
presents unique analytical challenges. We determined ex-
pression in six samples taken before and seven after the onset
of labor at term. In order to compare the differences in
samples taken before and after labor, the t-test for the
difference in expression was performed and the p-value was
calculated. The genes were ranked according to this value,
not to determine signiﬁcance, which would be inappropriate
for this number of comparisons, but to determine genes that
Table 3. Continued
Cluster GenBank ID Gene Name Change Fold p Function
11 Z46606 Matrix-associated, actin-dependent regulator
of chromatin a3
  1.93 0.0233 Transcription regulator that binds CA4, which in turn
binds SURB7, known to bind CREBBP
12 U65093 Cbp/p300-interacting transactivator 2   2.42 0.0514 Transcription regulator binding CREBBP
12 U30246 Solute carrier 12 - sodium/potassium/chloride
transporter 2
  2.51 0.0496 Expression increased by MYOD1 regulated by CREBBP
12 X75252 Prostatic binding protein   1.59 0.0316 Decreases activity of chymotrypsin; binds RAF1 regulating TP53,
also regulated by CREBBP
12 U35139 Necdin   1.59 0.0287 Binds CREBBP; colony formation of mast, connective tissue,
and blood cells
12 AB006909 Microphthalmia-associated transcription factor   1.42 0.0502 Colony formation of mast, connective tissue, and blood cells
12 AB028972 Colony-stimulating factor 2 receptor alpha   2.31 0.0231 Colony formation of mast, connective tissue, and blood cells
Cluster number identifies a coincidence cluster of genes grouped together by K-means and hierarchical clustering methods where probability of chance co-clustering was p , 0.01. The
fold change is a ratio of the difference between labor and non-labor medians of gene expression to the non-labor median level of gene expression. The change sign indicates the direction
of the expression change in the labor samples comparing to non-labor. The p-value is given for the difference in gene expression in samples taken before and after labor. Gene function is
derived from the database of gene functions and interactions Ingenuity Pathway Analysis and Biological Knowledge Database.
DOI: 10.1371/journal.pmed.0030169.t003
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Gene Expression Profiles in Labordemonstrated the greatest and most consistent change in
labor. We did not correct for multiple comparisons since the
expression of the different genes is not independently
regulated. This method of analysis is likely to provide more
consistent data than techniques using fewer samples, dupli-
cate arrays on the same samples, or identiﬁcation of an
arbitrary change in expression [21,22]. By this method, any
difference in expression during labor of those genes with the
smallest p-values is unlikely to have arisen by chance due to
observer and instrument variability. Hence, the genes with
the most consistent change in expression during labor are
most likely to have an important function, although current
methodology does not allow primary changes in expression to
be distinguished from those secondary to increased contrac-
tility.
Although we cannot exclude false positives and negatives,
the lower the p-value the smaller the probability of a false
positive results. However, as the number of genes selected
increases, so does the chance of inclusion of a false positive
result, while the chance of a false negative one decreases.
False negative results may also occur due to wide inter-
patient variability. There are many potential causes of inter-
patient variability. Particularly important is that it cannot be
determined in non-laboring patients when parturition would
otherwise commence—that is, how close to the onset of labor
a non-laboring patient is.
It is likely that many changes in gene expression precede
the clinical signs of labor: for example, the steroid hormones
estrogen and progesterone are fundamentally important for
the maintenance of pregnancy and the onset of labor [4,7]. In
some species, such as the sheep, pregnancy is maintained by
progesterone and labor is caused by a dramatic fall in
progesterone. The decrease in progesterone concentration
increases the estrogen/progesterone ratio leading to contrac-
tions [25]. A fall in plasma progesterone has not been
demonstrated in women, although administration of anti-
progestins can induce labor [26]. This suggests that the
mechanism may be slightly different in women.
Our demonstration of a fall in the expression of a
modulator of estrogen receptor activity provides a mecha-
nism whereby the functional estrogen/progesterone ratio
could be increased without a change in plasma concentration
of either. REA is a protein that competitively and selectively
binds to the nuclear receptor reducing its function [13].
Although identiﬁed in breast cancer and placental cells, this
modulator has not been described in the human myome-
trium. REA and RXR (which also inhibits estrogen activity)
were both clustered into one group based on their decreased
expression pattern in labor. The expression of prothymosin
alpha (an antagonist of REA) is unchanged in labor and
further supports this hypothesis. Jointly, they demonstrate
existence of a pathway that may represent a novel mechanism
of uterine control [13].
During labor there are concomitant physiological changes
in the fundus, lower uterine segment, and cervix. The fundus
generates coordinated forceful uterine contractions while the
contractile lower segment elongates over the presenting part.
The cervix undergoes softening in late pregnancy with a
dramatic shortening and dilation during labor. Our data
demonstrate related marked spatial differences in gene
expression, consistent with previous publications using
alternative techniques for quantiﬁcation [12]. Some of these
differences in gene expression may, however, be due to cell
type. We have previously demonstrated that more than 98%
of cells in our lower segment biopsies are myometrial [8], and
fundal samples were taken from the peritoneal (outer) surface
to prevent decidual contamination. It is therefore unlikely
that changes in gene expression in the fundus and lower
segment were derived from non-myometrial cells. In contrast,
the cellular composition of the cervix is more heterogeneous,
and expression within the different cell types cannot be
discerned. Nevertheless, we considered that maintenance of
the physiological cellular environment was more important
than a homogenous cell population.
Oxytocin and prostaglandins are known to have a
fundamental role in human parturition [6]. Our gene array
data are consistent with existing evidence on these oxytocics.
Oxytocin is produced by the choriodecidua during human
labor [8] and acts on myometrial oxytocin receptors to cause
contraction. Since oxytocin is not produced in the myome-
trium but in other gestational tissues, it is reassuring that
there was no increase in myometrial expression of oxytocin
in our study. The increase in myometrial oxytocin receptor
formation precedes the onset of labor, and uterine expres-
sion increases from mid-pregnancy to term rather than at the
onset of labor [27]. Consistent with these data, we did not
demonstrate an increase in oxytocin expression in labor. In
contrast, we have previously demonstrated that expression of
myometrial secretory phospholipase A2 is increased in
samples taken after the onset of labor [15]. This enzyme
catalyzes mobilization of arachidonic acid from membrane
phospholipids for the synthesis of prostaglandins. Our gene
array results conﬁrm an increase in secretory phospholipase
A2 expression in myometrial samples taken after the onset of
labor and are consistent with a regulatory role for prosta-
glandins
Figure 4. Validation of the Microarray Findings by RT-PCR
Relative abundance of mRNA, normalized to S-18, encoding the gene for
REA, RXR, and GAPDH in the myometrium obtained from the uterine
fundus in five non-laboring (NL) and five spontaneously laboring (L)
patients. Box limits represent 25th and 75th quartiles, line within the box
represents median, and whiskers represent 5th and 95th percentiles.
DOI: 10.1371/journal.pmed.0030169.g004
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Gene Expression Profiles in LaborThere is no generally accepted statistical method to analyze
differences in gene expressions between groups, due to
correlation of expressions of individual genes. To validate
our ﬁndings, we conﬁrmed expression of genes with different
technique and demonstrated functional relationship of co-
expressed genes. We validated a proportion of our micro-
array ﬁndings by RT-PCR, and we were reassured that the
results using both techniques were consistent among all
tested genes. We also analyzed the patterns of expression by
two techniques: K-means and hierarchical clustering.
Although these techniques may not be completely independ-
ent, the method of gene clustering is different and hence the
combination provides additional conﬁdence for the identi-
ﬁcation of networks of co-regulated genes. Prior studies have
shown that co-expressed genes have been demonstrated to be
functionally related and to participate in common biological
processes deﬁned by the Gene Ontology database. These
relationships are identiﬁed across species and functional
categories [28–31]. The identiﬁcation within each cluster of
genes with similar functions pertinent to labor strengthens
our hypothesis that these genes are co-regulated. It is likely
that expression of a particular gene can regulate expression
of a second, which may itself inﬂuence a third. In this way, a
single controlling mechanism may induce a multitude of
phenotypic alterations leading to a change in function.
Furthermore, transcription regulating factors (such as CAAT
enhancer binding protein, CEBP, which is increased after
labor in the lower segment) may promote transcription for
numerous contraction-associated genes. Indeed, CEBP bind-
ing to the oxytocin receptor promoter has recently been
demonstrated [32]. We anticipate that elucidating the net-
works of genes associated with labor will enable a more
holistic understanding of the process, leading to more
rational methods for manipulating uterine contraction.
In summary, we have demonstrated consistent changes in
gene expression in the human lower segment, fundus, and
cervix in association with labor. A number of novel-to-labor
genes have been identiﬁed in addition to networks of co-
expressed genes. There are marked tissue and spatial differ-
ences in gene expression in the uterus during parturition.
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Editors’ Summary
Background. Childbirth, or labor, although a basic event in life, is
actually a complex process that involves three parts of the uterus
(womb) working together to expel the baby. One particularly important
part of the process, which is poorly understood, is how labor begins. The
actual changes that occur in the uterus once labor has begun are well
known, and include contractions in the muscle of the uterus wall (the
myometrium) and dilation of the cervix (the neck of the womb). Some of
the triggers for these changes are also known: for example, in non-
primate animals changes in the blood levels of the hormones estrogen
and progesterone and changes in the membranes that surround the
fetus. Previous studies have suggested that these effects are likely, in
turn, to be triggered by changes in many genes, but exactly which ones
is not clear.
Why Was This Study Done? Learning more about which genes are
important in the various stages of labor may help to design treatments
for the various problems that occur in labor (such as failure of labor to
begin, or, alternatively, preterm labor). Little is known about the genes
that trigger, or are necessary for, labor to start and to continue in a
coordinated fashion. A technology known as DNA microarrays allows
researchers to take a sample from any part of the body and use it to look
at how active many thousands of genes are, all at the same time. By
analyzing these results, it is possible to suggest either single genes or
groups of genes that may be important in a particular process.
What Did the Researchers Do and Find? The authors took samples
from the uterus top, lower part, and cervix of six women before their
labor started, and seven from those whose labor had started. All women
were having cesarean sections either for medically indicated reasons, or
for choice. Then, in each of the samples in each woman, they looked at
12,626 known genes to see how active they were (scientists call these
active genes ‘‘expressed’’). They found that the changes in gene
expression were not, generally, the same across the three parts of the
uterus. Of the 500 genes with the largest change in expression, 28 were
common to both the upper and lower parts of the uterus, and this small
group of genes may be important in labor in both the upper and lower
parts of the uterus. The authors also classified the 500 genes into related
groups, and they believe that these relationships may be important in
controlling how labor happens.
What Do These Findings Mean? Identifying new genes or groups of
genes involved in labor is important for understanding how labor occurs.
One limitation of this study is the small number of women who were
studied—which is understandable, given the difficulty of obtaining such
samples—and the differences between the women studied. Another
difficulty with such studies is that the methods used to analyze the
expression patterns can affect the results. However, as is the custom with
these types of studies, all the results were placed in a public database so
anyone can look at them and, if they wish, do further analyses. In a
related Perspective article that was commissioned to comment on this
paper, Roberto Romero, one of the original reviewers of the paper, has
done just that. He finds that there were differences in the results of his
analyses and those of the authors’. He goes on to discuss the question of
how hard it is to use these techniques to look at complex problems, such
as how labor starts. Clearly, much more work needs to be done before it
is clear what all these results really mean. Nonetheless, these studies
have the potential to help to understand more about the basic science
behind labor.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030169.
  Medline Plus has a page of links on childbirth
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